Betaglucan 0.2% versus Imiquimod 5% in the Treatment of Ano Genital Warts (Agw) Randomized Triple Blind Study 102 Patients Aged 18 to 50 Years Old in Managua, Nicaragua, Period June to September 2019 "(Preliminary Report- Due to the COVID 19 Epidemic the Cclinical Trial was stopped on August 2019. Registered in ClinicalTrials.gov with NCT 03901690 and included in the Clinical Trials Panel of the World Health Organization since November 2020 | Zendy

AI Assistant Blog Pricing

Betaglucan 0.2% versus Imiquimod 5% in the Treatment of Ano Genital Warts (Agw) Randomized Triple Blind Study 102 Patients Aged 18 to 50 Years Old in Managua, Nicaragua, Period June to September 2019 "(Preliminary Report- Due to the COVID 19 Epidemic the Cclinical Trial was stopped on August 2019. Registered in ClinicalTrials.gov with NCT 03901690 and included in the Clinical Trials Panel of the World Health Organization since November 2020

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.